Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Differences in statin usage and target-goal achievement between departments at the same hospital.

Chen Z, Wang X, Ding Z, Fan P, Ma G.

PLoS One. 2012;7(12):e50466. doi: 10.1371/journal.pone.0050466. Epub 2012 Dec 10.

2.

Guideline-oriented ambulatory lipid-lowering therapy of patients at high risk for cardiovascular events by cardiologists in clinical practice: the 2L cardio registry.

Gitt AK, Juenger C, Jannowitz C, Karmann B, Senges J, Bestehorn K.

Eur J Cardiovasc Prev Rehabil. 2009 Aug;16(4):438-44. doi: 10.1097/HJR.0b013e32832a4e25.

PMID:
19369876
4.

Current cholesterol guidelines and clinical reality: a comparison of two cohorts of coronary artery disease patients.

Vonbank A, Saely CH, Rein P, Sturn D, Drexel H.

Swiss Med Wkly. 2013 Jul 7;143:w13828. doi: 10.4414/smw.2013.13828.

5.
7.
8.

Persistent lipid abnormalities in statin-treated patients and predictors of LDL-cholesterol goal achievement in clinical practice in Europe and Canada.

Gitt AK, Drexel H, Feely J, Ferrières J, Gonzalez-Juanatey JR, Thomsen KK, Leiter LA, Lundman P, da Silva PM, Pedersen T, Wood D, Jünger C, Dellea PS, Sazonov V, Chazelle F, Kastelein JJ; DYSIS Investigators.

Eur J Prev Cardiol. 2012 Apr;19(2):221-30. doi: 10.1177/1741826711400545. Epub 2011 Mar 10.

PMID:
21450578
9.
10.

Lipid levels and low-density lipoprotein cholesterol goal attainment in diabetic patients: rosuvastatin compared with other statins in usual care.

Harley CR, Gandhi SK, Heien H, McDonough K, Nelson SP.

Expert Opin Pharmacother. 2008 Apr;9(5):669-76. doi: 10.1517/14656566.9.5.669.

PMID:
18345946
11.

The use over time of statins in coronary patients in an Italian tertiary referral center.

Gaspardone A, Proietti I, Altamura L, Tomai F, Versaci F, Crea F, Chiariello L, Gioffrè PA.

Ital Heart J. 2001 Nov;2(11):848-53.

PMID:
11770871
12.

Current status of cholesterol goal attainment after statin therapy among patients with hypercholesterolemia in Asian countries and region: the Return on Expenditure Achieved for Lipid Therapy in Asia (REALITY-Asia) study.

Kim HS, Wu Y, Lin SJ, Deerochanawong C, Zambahari R, Zhao L, Zhang Q, Yan P.

Curr Med Res Opin. 2008 Jul;24(7):1951-63. doi: 10.1185/03007990802138731 . Epub 2008 Jun 10.

PMID:
18547466
13.

Cholesterol level goal attainment with statins: clinical management guideline recommendations versus management in actual clinical practice.

Heintjes EM, Penning-van Beest FJ, Plat AW, Meerding WJ, Webb K, Sturkenboom MC, Herings RM.

Pharmacotherapy. 2012 Jul;32(7):631-41. doi: 10.1002/j.1875-9114.2011.01086.x.

PMID:
22760692
14.

[Effects of statins on coronary atherosclerotic plaque in patients with coronary heart disease and type 2 diabetes with mild elevated LDL-C].

Wang XF, Lu CZ, Chen X.

Zhonghua Xin Xue Guan Bing Za Zhi. 2009 Apr;37(4):339-42. Chinese.

PMID:
19791470
15.

Ezetimibe/simvastatin vs simvastatin in coronary heart disease patients with or without diabetes.

Rotella CM, Zaninelli A, Le Grazie C, Hanson ME, Gensini GF.

Lipids Health Dis. 2010 Jul 27;9:80. doi: 10.1186/1476-511X-9-80.

16.

Cholesterol end points predict outcome in patients with coronary disease: quality improvement metrics from the enhancing secondary prevention in coronary artery disease (ESP-CAD) trial.

McAlister FA, Majumdar SR, Lin M, Bakal J, Fradette M, Anderson T.

Can J Cardiol. 2014 Dec;30(12):1627-32. doi: 10.1016/j.cjca.2014.07.008. Epub 2014 Jul 16.

PMID:
25307535
17.

Effects of switching statins on achievement of lipid goals: Measuring Effective Reductions in Cholesterol Using Rosuvastatin Therapy (MERCURY I) study.

Schuster H, Barter PJ, Stender S, Cheung RC, Bonnet J, Morrell JM, Watkins C, Kallend D, Raza A; Effective Reductions in Cholesterol Using Rosuvastatin Therapy I study group.

Am Heart J. 2004 Apr;147(4):705-13.

PMID:
15077101
18.

HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.

Tani S, Nagao K, Hirayama A.

Am J Cardiovasc Drugs. 2011 Dec 1;11(6):411-7. doi: 10.2165/11594620-000000000-00000.

PMID:
22149320
20.

Persistent lipid abnormalities in statin-treated coronary artery disease patients with and without diabetes in China.

Wei Y, Guo H, The E, Che W, Shen J, Hou L, Zhao S, Ye P, Li G, Wang D, Jie Q, Hu D.

Int J Cardiol. 2015 Mar 1;182:469-75. doi: 10.1016/j.ijcard.2015.01.024. Epub 2015 Jan 7.

PMID:
25612824
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk